v3.26.1
Convertible Preferred Stock and Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2026
Convertible Preferred Stock and Stockholders’ Equity [Abstract]  
Schedule of Preferred Stock

As of March 31, 2026, Series B preferred stock consisted of the following (in thousands, except share data):

 

   March 31, 2026 
   Preferred
Stock
Authorized
   Preferred
Stock Issued
and
Outstanding
   Carrying
Value
   Common
Stock Issuable
Upon
Conversion
 
Series B preferred stock   251,504    137,138   $2,931    11,428,149 
                     
Schedule of Common Stock Reserved for Future Issuance

As of March 31, 2026 and December 31, 2025, the Company had common stock reserved for future issuance as follows:

 

   March 31,
2026
   December 31,
2025
 
Shares issuable on conversion of Series B preferred stock   11,428,149    11,428,149 
Shares issuable upon exercise of pre-funded warrants   6,886,621    6,943,849 
Shares issuable upon exercise of warrants under the Paruka Warrant Obligation   971,930    971,930 
Outstanding and issued stock options   5,297,351    3,950,958 
Outstanding and issued employee warrants   2,767,511    3,029,510 
Outstanding and issued restricted stock units   396,145    
 
Shares available for grant under 2024 Stock Incentive Plan   6,129,190    4,600,217 
Shares available for grant under 2024 Employee Stock Purchase Plan   975,922    975,922 
Total shares of common stock reserved   34,852,819    31,900,535